Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Otsuka nets Yen198.6bn via its IPO on the Tokyo Stock Exchange

Executive Summary

Otsuka Holdings Co. Ltd., the diversified parent company of Otsuka Pharmaceutical Co. Ltd., has raised Yen198.6bn ($2.3bn) through its oversubscribed initial public offering of 90mm shares at Yen2,100 ($25.16), the lower end of its Yen2,000-2,400 range. About 60% of the shares were sold to overseas investors. Otsuka will trade on the First Section of the Tokyo Stock Exchange.
Deal Industry
  • Diversified
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register